WO2002066021A3 - Inhibitoren der protein kinase d und der protein kinase 2 als mittel zur hemmung von tumorzellen und zur stimulierung der angiogehese - Google Patents
Inhibitoren der protein kinase d und der protein kinase 2 als mittel zur hemmung von tumorzellen und zur stimulierung der angiogehese Download PDFInfo
- Publication number
- WO2002066021A3 WO2002066021A3 PCT/DE2002/000652 DE0200652W WO02066021A3 WO 2002066021 A3 WO2002066021 A3 WO 2002066021A3 DE 0200652 W DE0200652 W DE 0200652W WO 02066021 A3 WO02066021 A3 WO 02066021A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibitors
- protein kinase
- agents
- angiogenesis
- tumour cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002252950A AU2002252950A1 (en) | 2001-02-22 | 2002-02-21 | Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis |
DE10290562T DE10290562D2 (de) | 2001-02-22 | 2002-02-21 | Zielkomplex als Mittel zur Hemmung von Tumorzellen und zur Stimulierung der Angiogenese |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10109883.9 | 2001-02-22 | ||
DE10109883 | 2001-02-22 | ||
DE10117266 | 2001-03-30 | ||
DE10117266.4 | 2001-03-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002066021A2 WO2002066021A2 (de) | 2002-08-29 |
WO2002066021A3 true WO2002066021A3 (de) | 2002-10-31 |
Family
ID=26008653
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2002/000652 WO2002066021A2 (de) | 2001-02-22 | 2002-02-21 | Inhibitoren der protein kinase d und der protein kinase 2 als mittel zur hemmung von tumorzellen und zur stimulierung der angiogehese |
PCT/DE2002/000653 WO2002066027A1 (de) | 2001-02-22 | 2002-02-21 | Mittel zur hemmung von tumorzellen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2002/000653 WO2002066027A1 (de) | 2001-02-22 | 2002-02-21 | Mittel zur hemmung von tumorzellen |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002252950A1 (de) |
DE (4) | DE10207881A1 (de) |
WO (2) | WO2002066021A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10147088A1 (de) * | 2001-09-25 | 2003-04-17 | Medinnova Ges Med Innovationen | Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Erkrankungen, die mit Zellwachstumsstörungen einhergehen und Testsystem zum Auffinden solcher Wirksubstanzen |
ES2245612B1 (es) * | 2004-06-29 | 2007-08-16 | Universidad De Barcelona | Nuevo uso terapeutico del formoterol. |
ITFI20050031A1 (it) * | 2005-02-21 | 2006-08-22 | Stefan Coccoloni | Una composizione farmaceutica atta a prevenire l'invecchiamento e l'insorgere di malattie vascolari,neoplastiche,cutanee e dell'apparato pilifero |
GB0625270D0 (en) * | 2006-12-19 | 2007-01-31 | Univ Leicester | Angiogenesis |
US9095606B1 (en) | 2010-11-13 | 2015-08-04 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
US9066974B1 (en) | 2010-11-13 | 2015-06-30 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9003057D0 (sv) * | 1990-09-26 | 1990-09-26 | Astra Ab | New process |
US5135954A (en) * | 1991-05-24 | 1992-08-04 | The Regents Of The University Of California | Use of formoterol for treatment of tissue injury |
-
2002
- 2002-02-21 WO PCT/DE2002/000652 patent/WO2002066021A2/de not_active Application Discontinuation
- 2002-02-21 DE DE10207881A patent/DE10207881A1/de not_active Withdrawn
- 2002-02-21 WO PCT/DE2002/000653 patent/WO2002066027A1/de not_active Application Discontinuation
- 2002-02-21 DE DE10290563T patent/DE10290563D2/de not_active Expired - Fee Related
- 2002-02-21 AU AU2002252950A patent/AU2002252950A1/en not_active Abandoned
- 2002-02-21 DE DE10290562T patent/DE10290562D2/de not_active Expired - Fee Related
- 2002-02-21 DE DE10207882A patent/DE10207882A1/de not_active Withdrawn
Non-Patent Citations (9)
Title |
---|
DELMAS D ET AL: "RESVERATROL, AN EFFICIENT INHIB ITOR OF HUMAN COLORECTAL CANCER CELL PROLIFERATION", BIOLOGY OF THE CELL, ELSEVIER, PARIS, FR, vol. 2, no. 92, April 2000 (2000-04-01), pages 163, XP001069130, ISSN: 0248-4900 * |
HSIEH TZE-CHEN ET AL: "Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines", EXPERIMENTAL CELL RESEARCH, SAN DIEGO, CA, US, vol. 249, no. 1, 25 May 1999 (1999-05-25), pages 109 - 115, XP002192994, ISSN: 0014-4827 * |
KHAR A ET AL: "Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 445, no. 1, 19 February 1999 (1999-02-19), pages 165 - 168, XP004259868, ISSN: 0014-5793 * |
MEHTA K ET AL: "ANTIPROLIFERATIVE EFFECT OF CURCUMIN (DIFERULOYLMETHANE) AGAINST HUMAN BREAST TUMOR CELL LINES", ANTI-CANCER DRUGS, OXFORD, GB, vol. 8, June 1997 (1997-06-01), pages 470 - 481, XP000933933, ISSN: 0959-4973 * |
MEISHIANG ET AL: "Cancer Chemopreventive Activity of Resveratrol, a natural product Derived from grapes", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 275, 10 January 1997 (1997-01-10), pages 218 - 220, XP002124508, ISSN: 0036-8075 * |
STEELE V E ET AL: "CANCER CHEMOPREVENTION DRUG DEVELOPMENT STRATEGIES FOR RESVERATROL", PHARMACEUTICAL BIOLOGY, SWETS AND ZEITLINGER, LISSE,, NL, vol. 36, no. SUPPL, 1998, pages 62 - 68, XP000910995, ISSN: 1388-0209 * |
UENO N T ET AL: "GROWTH SUPPRESSION OF LOW HER-2/NEU-EXPRESSING BREAST CANCER CELL LINE MDA-MB-435 BY TYROSINE KINASE INHIBITOR EMODIN", ONCOLOGY REPORTS, NATIONAL HELLENIC RESEARCH FOUNDATION, ATHENS, GR, vol. 3, no. 3, 1 May 1996 (1996-05-01), pages 509 - 511, XP000672384, ISSN: 1021-335X * |
XIONG Y P ET AL: "MOLECULAR TARGETS OF RESVERATROL ON HUMAN COLON CANCER CELL LINES", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 55, no. 40, March 1999 (1999-03-01), pages 55, XP001063169, ISSN: 0197-016X * |
ZHANG L ET AL: "SENSITIZATION OF HER-2/NEU-OVEREXPRESSING NON-SMALL CELL LUNG CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS BY TYROSINE KINASE INHIBITOR EMODIN", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 12, no. 3, 1 February 1996 (1996-02-01), pages 571 - 576, XP000672224, ISSN: 0950-9232 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002066027A1 (de) | 2002-08-29 |
DE10207881A1 (de) | 2003-02-13 |
DE10207882A1 (de) | 2003-02-27 |
DE10290562D2 (de) | 2004-04-29 |
AU2002252950A1 (en) | 2002-09-04 |
WO2002066021A2 (de) | 2002-08-29 |
DE10290563D2 (de) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001029025A3 (en) | Tyrosine kinase inhibitors | |
WO2001028993A3 (en) | Tyrosine kinase inhibitors | |
IL148385A0 (en) | Tyrosine kinase inhibitors | |
HUP9901628A2 (hu) | Eljárások és készítmények alfa v béta5-közvetítette angiogenezis gátlására | |
EP1304110A3 (de) | Bicyclische heteroaromatische Verbindungen als Protein Tyrosine Kinase Inhibitoren | |
GB0108770D0 (en) | Inhibitors | |
WO2003092595A3 (en) | Tyrosine kinase inhibitors | |
TR199900048T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler | |
WO2001081346A3 (en) | Inhibitors of human phosphatidyl-inositol 3-kinase delta | |
HK1014672A1 (en) | Methods for modulating t cell responses by manipu lating intracellular signal transduction. | |
AU3857501A (en) | Tyrosine kinase inhibitors | |
MY139689A (en) | Imidazotriazines as protein kinase inhibitors | |
WO2003037252A3 (en) | Tyrosine kinase inhibitors | |
WO1999050251A3 (en) | Cyclin dependent kinase inhibitors | |
WO2004030620A3 (en) | Novel tyrosine kinase inhibitors | |
DE60215682D1 (de) | AZAOXOINDOL DERIVATE ALS Trk PROTEIN KINASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBS UND CHRONISCHEM SCHMERZ | |
WO2002066021A3 (de) | Inhibitoren der protein kinase d und der protein kinase 2 als mittel zur hemmung von tumorzellen und zur stimulierung der angiogehese | |
WO2001064218A3 (en) | Farnesyl protein transferase inhibitor combinations | |
WO2003020699A3 (en) | Tyrosine kinase inhibitors | |
MXPA02010759A (es) | Derivados del acido (2-oxindol-3-ilidenil) acetico y su uso como inhibidores de la proteina quinasa. | |
WO2003015717A3 (en) | Tyrosine kinase inhibitors | |
WO2003077874A3 (en) | Substituted tetrahydroisoquinoline compounds, methods of making, and their use | |
CA2472008A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors | |
ATE452194T1 (de) | Lipidkinase | |
WO2003004631A3 (en) | USE OF INHIBITORS OF EXPRESSION OR ACTIVITY OF p8/com1 FOR TREATING TUMORS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
REF | Corresponds to |
Ref document number: 10290562 Country of ref document: DE Date of ref document: 20040429 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10290562 Country of ref document: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |